Uncategorized

Trefoil Therapeutics Appoints Thomas M. Tremblay, RN BSN, Vice President, Clinical Development

by Business Wire • 2020/02/10 • 0 Comments

SAN DIEGO--(BUSINESS WIRE)--Trefoil Therapeutics appoints Thomas M. Tremblay, RN BSN, Vice President, Clinical Development to lead corneal disease clinical program for TTHX1114

Full Story →

← VIDEO: Aerie official shares phase 4 trial data on Rhopressa use

New treatment effective at reversing the manifestations of thyroid eye disease →

Post navigation